Comprehensive-immunopeptidomics analysis reveals presentation of potential neoantigens carrying cancer driver mutations
Y. Minegishi, K. Kiyotani, K. Nemoto, Y. Inoue, Y. Haga, R. Fujii, N. Saichi, S. Nagayama, K. Ueda
This study identifies neoantigens with cancer driver mutations using immunopeptidomics techniques, revealing new potential targets for cancer immunotherapy.
bioRxiv · Apr 9, 2021 · PreprintCancer Biology